OMX Copenhagen PI
1.311,77
PKT
-19,73
PKT
-1,48
%
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.06.20 | A.P. Moeller - Maersk A-S (B) overweight | JP Morgan Chase & Co. | |
| 29.05.20 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
| 28.05.20 | A.P. Moeller - Maersk A-S (B) Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Jefferies & Company Inc. | |
| 21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Novo Nordisk Neutral | UBS AG | |
| 14.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.05.20 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 13.05.20 | A.P. Moeller - Maersk A-S (B) neutral | Goldman Sachs Group Inc. | |
| 13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.05.20 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 12.05.20 | A.P. Moeller - Maersk A-S (B) Hold | Kepler Cheuvreux | |
| 11.05.20 | Novo Nordisk Neutral | UBS AG | |
| 07.05.20 | Novo Nordisk overweight | Barclays Capital | |
| 07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.20 | Novo Nordisk buy | UBS AG | |
| 06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 21.04.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 17.04.20 | Novo Nordisk buy | UBS AG | |
| 17.04.20 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 15.04.20 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
| 15.04.20 | Novo Nordisk buy | UBS AG | |
| 15.04.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 15.04.20 | Novo Nordisk Outperform | Bernstein Research | |
| 14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.04.20 | Novo Nordisk overweight | Barclays Capital | |
| 07.04.20 | Novo Nordisk Hold | Deutsche Bank AG | |
| 07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.04.20 | Novo Nordisk Hold | Deutsche Bank AG | |
| 31.03.20 | Novo Nordisk Neutral | Oddo BHF | |
| 27.03.20 | A.P. Moeller - Maersk A-S (B) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.03.20 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.20 | Novo Nordisk buy | UBS AG | |
| 18.03.20 | Novo Nordisk Outperform | Bernstein Research |